Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is traded on the NYSE under the symbol “RJF.” As of November 21, 2025, we had 347 holders of record of our common stock. Shares of our common stock are held by a substantially greater number of beneficial owners, whose shares are held of record by banks, brokers, and other financial institutions.
See Note 19 of the Notes to Consolidated Financial Statements of this Form 10-K for information regarding our intentions for paying cash dividends and the related capital restrictions.
Information related to our compensation plans under which equity securities are authorized for issuance is presented in Note 22 of the Notes to Consolidated Financial Statements and Part III, Item 12 of this Form 10-K.
We did not have any sales of unregistered securities for the fiscal years ended September 30, 2025, 2024, or 2023.
We purchase our own stock from time to time in conjunction with a number of activities, each of which is described in the following paragraphs. The following table presents information on our purchases of our own stock, on a monthly basis, for the year ended September 30, 2025.
Total number of shares
purchased Average price
per share Number of shares purchased as part of publicly announced plans or programs Approximate dollar value (in millions) at each month-end, of securities that may yet be purchased under the plans or programs
October 1, 2024 – October 31, 2024 — $ — — $644
November 1, 2024 – November 30, 2024 427 $ 154.42 — $644
December 1, 2024 – December 31, 2024 371,287 $ 161.98 310,302 $1,450
First quarter 371,714 $ 161.97 310,302
January 1, 2025 – January 31, 2025 23,435 $ 162.69 — $1,450
February 1, 2025 – February 28, 2025 315,686 $ 158.54 315,391 $1,400
March 1, 2025 – March 31, 2025 1,402,024 $ 142.78 1,399,870 $1,200
Second quarter 1,741,145 $ 145.91 1,715,261
April 1, 2025 – April 30, 2025 1,559,201 $ 125.67 1,555,458 $1,005
May 1, 2025 – May 31, 2025 712,149 $ 147.48 711,957 $900
June 1, 2025 – June 30, 2025 1,019,018 $ 148.17 1,019,018 $749
Third quarter 3,290,368 $ 137.36 3,286,433
July 1, 2025 – July 31, 2025 830,888 $ 160.03 830,888 $616
August 1, 2025 – August 31, 2025 445,070 $ 165.30 444,478 $542
September 1, 2025 – September 30, 2025 831,339 $ 172.71 831,339 $399
Fourth quarter 2,107,297 $ 166.14 2,106,705
Fiscal year total 7,510,524 $ 148.64 7,418,701
In December 2024, the Board of Directors authorized repurchase of our common stock in an aggregate amount of up to $1.5 billion, which replaced the previous authorization. For additional information about our share repurchase activities, see Note 19 of the Notes to Consolidated Financial Statements of this Form 10-K.
38
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES
Index
In the preceding table, the total number of shares purchased includes shares purchased pursuant to the Restricted Stock Trust Fund, which was established to acquire our common stock in the open market and used to settle restricted stock units granted as a retention vehicle for certain employees of our wholly-owned Canadian subsidiaries. For additional information on this trust fund, see Notes 2 and 9 of the Notes to Consolidated Financial Statements of this Form 10-K. These activities do not utilize the repurchase authorization presented in the preceding table.
The total number of shares purchased also includes shares repurchased as a result of employees surrendering shares as payment for option exercises or withholding taxes. These activities do not utilize the repurchase authorization presented in the preceding table.
ITEM 6. RESERVED
39
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES
Index